Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

The FDA amended the EUAs for the Pfizer-BioNTech and Moderna COVID-19 Vaccines to allow an additional dose in certain immunocompromised individuals, specifically solid organ transplant recipients or those with conditions that are considered to have an equivalent level of immunocompromise.

Original source: http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised

Related Posts